Judith M. Matthews - Jun 23, 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Financial Officer
Signature
/s/ Judith M. Matthews
Stock symbol
ITRM
Transactions as of
Jun 23, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 04:05 PM
Next filing
Mar 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +1.94M $0.00 1.94M Jun 23, 2021 Ordinary Shares 1.94M $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.